Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Current Leases (2019 - 2025)

Historic Current Leases for Heron Therapeutics (HRTX) over the last 7 years, with Q3 2025 value amounting to $780000.0.

  • Heron Therapeutics' Current Leases fell 7599.26% to $780000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $780000.0, marking a year-over-year decrease of 7599.26%. This contributed to the annual value of $3.0 million for FY2024, which is 123.58% down from last year.
  • Latest data reveals that Heron Therapeutics reported Current Leases of $780000.0 as of Q3 2025, which was down 7599.26% from $1.5 million recorded in Q2 2025.
  • Heron Therapeutics' 5-year Current Leases high stood at $3.3 million for Q3 2021, and its period low was $780000.0 during Q3 2025.
  • Over the past 5 years, Heron Therapeutics' median Current Leases value was $2.8 million (recorded in 2023), while the average stood at $2.7 million.
  • Per our database at Business Quant, Heron Therapeutics' Current Leases skyrocketed by 2379.84% in 2024 and then crashed by 7599.26% in 2025.
  • Heron Therapeutics' Current Leases (Quarter) stood at $2.4 million in 2021, then increased by 11.46% to $2.7 million in 2022, then rose by 14.14% to $3.1 million in 2023, then dropped by 1.24% to $3.0 million in 2024, then tumbled by 74.32% to $780000.0 in 2025.
  • Its Current Leases stands at $780000.0 for Q3 2025, versus $1.5 million for Q2 2025 and $2.3 million for Q1 2025.